Natera (NTRA) Receiving Somewhat Positive News Coverage, Report Shows

Media headlines about Natera (NASDAQ:NTRA) have been trending somewhat positive recently, Accern reports. The research firm identifies positive and negative news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Natera earned a news impact score of 0.21 on Accern’s scale. Accern also gave news articles about the medical research company an impact score of 45.1407644179848 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Several research analysts have recently weighed in on NTRA shares. Zacks Investment Research raised Natera from a “sell” rating to a “hold” rating in a research note on Friday, September 22nd. Morgan Stanley reaffirmed an “overweight” rating and set a $16.00 target price (up from $13.00) on shares of Natera in a research note on Friday, October 6th. Robert W. Baird reaffirmed a “buy” rating on shares of Natera in a research note on Tuesday, October 24th. Canaccord Genuity reaffirmed a “buy” rating and set a $15.00 target price on shares of Natera in a research note on Tuesday, November 14th. Finally, Cowen reaffirmed a “buy” rating and set a $12.00 target price on shares of Natera in a research note on Thursday, December 21st. One analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company. Natera currently has a consensus rating of “Hold” and a consensus price target of $14.50.

Shares of Natera (NASDAQ NTRA) traded up $0.39 during mid-day trading on Friday, hitting $10.10. The stock had a trading volume of 110,500 shares, compared to its average volume of 101,800. The company has a current ratio of 1.85, a quick ratio of 1.75 and a debt-to-equity ratio of 2.43. The firm has a market cap of $544.68 and a P/E ratio of -4.16. Natera has a twelve month low of $7.35 and a twelve month high of $14.76.

Natera (NASDAQ:NTRA) last announced its earnings results on Wednesday, November 8th. The medical research company reported ($0.51) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.47) by ($0.04). The business had revenue of $56.66 million for the quarter, compared to analyst estimates of $55.31 million. Natera had a negative return on equity of 197.09% and a negative net margin of 62.34%. The company’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.50) earnings per share. research analysts forecast that Natera will post -2.15 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Natera (NTRA) Receiving Somewhat Positive News Coverage, Report Shows” was first posted by Markets Daily and is the property of of Markets Daily. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://www.themarketsdaily.com/2018/01/12/natera-ntra-receiving-somewhat-positive-news-coverage-report-shows.html.

Natera Company Profile

Insider Buying and Selling by Quarter for Natera (NASDAQ:NTRA)

Receive News & Ratings for Natera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply